Search - tctmd.com

Displaying 1 - 20 of 125

Sort: Relevancy | Date

Presentation

Clopidogrel vs Ticagrelor or Prasugrel in Patients 70 Years or Older With NTSE ACS: POPular Age

April 27, 2020

Presentation JIM 2018

Case: Immediate PCI + downstream clopidogrel

Presenter: Giuseppe Tarantini

February 23, 2018

Presentation JIM 2018

Clinical Case: Management of Long-Term DAPT

Presenter: Ugo Limbruno

February 23, 2018

Presentation

Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With DES

August 07, 2017

Presentation

Association Between CKD and Outcomes With Use of Prasugrel vs Clopidogrel in PCI for ACS

August 04, 2017

Presentation EuroPCR 2017

Prasugrel, Ticagrelor and Clopidogrel in PPCI for STEMI: An Analysis of Comparative Clinical Outcomes from the UK BCIS National Registry

Presenter: Mamas A. Mamas

May 22, 2017

Presentation

Influence of Smoking on the Antiplatelet Effect of Clopidogrel Differs by Dose: GRAVITAS

Presenter: Grant Reed

February 28, 2016

Presentation

Ticagrelor vs Clopidogrel in Troponin-Negative Patients With Low-Risk ACS Undergoing Ad Hoc PCI

Presenter: Dominick J. Angiolillo

February 09, 2016

Presentation

Timing of Clopidogrel Loading in US Practice

Presenter: Gregg W. Stone

February 08, 2016

Presentation

Premature Clopidogrel Discontinuation After DES Placement in a Large Urban Safety-Net Hospital

Presenter: H. Khalili

December 09, 2015

Presentation

ADAPT-DES Subanalaysis: Proton Pump Inhibitors (PPIs), Platelet Reactivity, and Cardiovascular Outcomes After DES in Clopidogrel-Treated Patients

Presenter: Giora Weisz

October 28, 2015

Presentation

RECLOSE-3: Prasugrel in Clopidogrel Nonresponders Undergoing PCI

Presenter: R. Valenti

September 17, 2015

Presentation

Concomitant PPI Use, Platelet Activity, and Clinical Outcomes in ACS Patients Treated With Prasugrel vs Clopidogrel and Managed Without Revascularization

Presenter: Jose Carlos Nicolau

June 17, 2015

Presentation

PROMETHEUS: Clinical Assessment of ACS Patients Managed With PCI and Treated With Prasugrel or Clopidogrel

Presenter: Usman Baber

May 11, 2015

Presentation

Ticagrelor vs Clopidogrel in Troponin-Negative ACS Patients Undergoing Ad Hoc PCI

Presenter: Roxana Mehran

May 08, 2015

Presentation

Prognostic Impact of Clopidogrel Pretreatment in Patients With ACS Managed Invasively

Presenter: Manuel Almendro-Delia

February 05, 2015

Presentation

Impact of Diabetes and Metabolic Syndrome on Acute and Chronic On-Clopidogrel Platelet Reactivity in Patients with Stable CAD Receiving DES

Presenter: Laurent Feldman

October 06, 2014

Presentation

VerifyNow in DIabetes High On-Treatment Platelet Reactivity: Switching from Clopidogrel to Prasugrel

Presenter: J.M. Cubero

October 06, 2014

Presentation TCT 2014

Safety and Effectiveness of Prasugrel vs_ Clopidogrel in the Setting of Bivalirudin vs_ Heparin Use: 30-day Results from TRANSLATE-ACS

Presenter: Timothy Henry

September 16, 2014

Presentation TCT 2014

Efficacy and safety of switching from clopidogrel to prasugrel in diabetic patients with acute coronary syndromes treated with drug-elunting stents: results of the ESCAPADA study

Presenter: Armando P?rez de Prado

September 16, 2014

Advertisement

Clopidogrel vs Ticagrelor or Prasugrel in Patients 70 Years or Older With NTSE ACS: POPular Age

Case: Immediate PCI + downstream clopidogrel

Clinical Case: Management of Long-Term DAPT

Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With DES

Association Between CKD and Outcomes With Use of Prasugrel vs Clopidogrel in PCI for ACS

Prasugrel, Ticagrelor and Clopidogrel in PPCI for STEMI: An Analysis of Comparative Clinical Outcomes from the UK BCIS National Registry

Influence of Smoking on the Antiplatelet Effect of Clopidogrel Differs by Dose: GRAVITAS

Ticagrelor vs Clopidogrel in Troponin-Negative Patients With Low-Risk ACS Undergoing Ad Hoc PCI

Timing of Clopidogrel Loading in US Practice

Premature Clopidogrel Discontinuation After DES Placement in a Large Urban Safety-Net Hospital

ADAPT-DES Subanalaysis: Proton Pump Inhibitors (PPIs), Platelet Reactivity, and Cardiovascular Outcomes After DES in Clopidogrel-Treated Patients

RECLOSE-3: Prasugrel in Clopidogrel Nonresponders Undergoing PCI

Concomitant PPI Use, Platelet Activity, and Clinical Outcomes in ACS Patients Treated With Prasugrel vs Clopidogrel and Managed Without Revascularization

PROMETHEUS: Clinical Assessment of ACS Patients Managed With PCI and Treated With Prasugrel or Clopidogrel

Ticagrelor vs Clopidogrel in Troponin-Negative ACS Patients Undergoing Ad Hoc PCI

Prognostic Impact of Clopidogrel Pretreatment in Patients With ACS Managed Invasively

Impact of Diabetes and Metabolic Syndrome on Acute and Chronic On-Clopidogrel Platelet Reactivity in Patients with Stable CAD Receiving DES

VerifyNow in DIabetes High On-Treatment Platelet Reactivity: Switching from Clopidogrel to Prasugrel

Safety and Effectiveness of Prasugrel vs_ Clopidogrel in the Setting of Bivalirudin vs_ Heparin Use: 30-day Results from TRANSLATE-ACS

Efficacy and safety of switching from clopidogrel to prasugrel in diabetic patients with acute coronary syndromes treated with drug-elunting stents: results of the ESCAPADA study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content